Skip to main content
Clinical Trials/NCT01591226
NCT01591226CompletedNot Applicable

Effects of Caffeine and Sodium Citrate Ingestion in 1500m Wheelchair Racing Athletes

Swiss Paraplegic Research, Nottwil2 sites in 1 country9 target enrollmentStarted: February 1, 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
9
Locations
2
Primary Endpoint
Time

Study Overview

Brief Summary

A positive ergogenic effect of sodium citrate and caffeine ingestion in a short-term, high-intensity exercise task was shown by several studies. These studies were conducted with healthy, able-bodied subjects.

The aim of the study is to investigate whether caffeine or sodium citrate ingestion could enhance performance in spinal cord injured wheelchair athletes. It is a double blind, placebo controlled and randomized study.

Detailed Description

The athletes have to complete four 1500m tests on a training roller. Before each treatment they get different supplementations. Once they get sodium citrate and a placebo, once caffeine and a placebo, once sodium citrate and caffeine and for the fourth treatment they get twice a placebo. Two hours after starting with the supplementation they have to complete the 1500m as fast as possible. Time to complete 1500m, blood pH, plasma bicarbonate, sodium concentration, heart rate, oxygen consumption, blood lactate concentration and rate of perceived exertion (RPE) were measured.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Factorial
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 55 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • wheelchair athletes
  • national team
  • category T53 and T54

Exclusion Criteria

  • medicated
  • pregnant (for women)
  • cardiovascular and respiratory diseases

Outcomes

Primary Outcomes

Time

Time Frame: 3 weeks

Time to complete 1500m

Secondary Outcomes

  • blood pH, sodium concentration and plasma bicarbonate(during the 3 weeks of study phase)
  • Lactate Concentration(during the 3 weeks study phase)
  • rating of gastrointestinal stress(during the 3 weeks of study phase)
  • Rating of Perceived Exertion (RPE)(during the 3 weeks of study phase)
  • Heart Rate(during study phase of 3 week (4 tests))
  • Oxygen Consumption(during 3 weeks of study phase)

Investigators

Sponsor
Swiss Paraplegic Research, Nottwil
Sponsor Class
Network
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials